173 related articles for article (PubMed ID: 9690546)
1. Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors.
Pizer ES; Lax SF; Kuhajda FP; Pasternack GR; Kurman RJ
Cancer; 1998 Aug; 83(3):528-37. PubMed ID: 9690546
[TBL] [Abstract][Full Text] [Related]
2. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
4. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma.
Villena-Heinsen C; Meyberg R; Axt-Fliedner R; Reitnauer K; Reichrath J; Friedrich M
Anticancer Res; 2002; 22(4):2261-7. PubMed ID: 12174912
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.
Giuffrè G; Arena F; Scarfì R; Simone A; Todaro P; Tuccari G
Oncol Rep; 2006 Aug; 16(2):257-63. PubMed ID: 16820900
[TBL] [Abstract][Full Text] [Related]
9. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
[TBL] [Abstract][Full Text] [Related]
10. [Estrogen and progesterone receptors in endometrial carcinoma].
Guo Y; Dang Q
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
[TBL] [Abstract][Full Text] [Related]
11. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I
Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
14. [Contribution of immunohistochemistry and flow-cytometry in the study of endometrial pathology].
Amălinei C; Căruntu ID; Balan R; Cianga C; Cianga P
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):437-48. PubMed ID: 19295017
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of bcl-2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas.
Saegusa M; Okayasu I
J Pathol; 1997 Aug; 182(4):429-36. PubMed ID: 9306964
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinoma.
Gehrig PA; Van Le L; Olatidoye B; Geradts J
Cancer; 1999 Nov; 86(10):2083-9. PubMed ID: 10570435
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
19. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
Olech-Fudali E; Chibowski D; Skomra D; Walczyna B
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333
[TBL] [Abstract][Full Text] [Related]
20. [Microsatellite instability in endometrial neoplasms correlation with clinicopathologic parameters and estrogen receptor or progesterone receptor status].
Song Y; Lang J
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):273-6. PubMed ID: 11775905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]